Our Research Publications
Updated August 2025
| Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
|---|---|---|---|---|---|---|
| Canada's approach to SARS-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics | O'Brien SF, Asamoah-Boaheng M, Grunau B, Krajden M, Buckeridge DL, Goldfarb DM, Anderson M, Germain M, Brown P, Stein DR, Kandola K, Tipples G, Awadalla P, Lang A, Behl L, Fitzpatrick T, Drews SJ | 2024 | Can J Public Health | View Canada's approach to SARS-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics | Researchers | Epidemiology research |
| The International Society of Blood Transfusion (ISBT) Public Health Research Toolkit: A report from the Surveillance, Risk Assessment and Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party | Stanley J, Busch MP, Erikstrup C, Galel SA, Holmberg JA, Lewin A, O'Brien SF, Osiowy C, Patidar G, Russell WA, Spencer BR, Higgs C | 2024 | Vox Sang | View The International Society of Blood Transfusion (ISBT) Public Health Research Toolkit: A report from the Surveillance, Risk Assessment and Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party | Blood operators | Epidemiology research |
| Advancing in vivo assessment of red blood cell transfusions: A call for radiation-free methods in transfusion medicine | Yazdanbakhsh M, Acker JP | 2024 | Transfus Apher Sci | View Advancing in vivo assessment of red blood cell transfusions: A call for radiation-free methods in transfusion medicine | Researchers | Benchmarking and standard setting |
| Improving safety and conserving resources by reducing unnecessary transfusions | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Improving safety and conserving resources by reducing unnecessary transfusions | General public | Other |
| Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines | Callum J, Skubas NJ, Bathla A, Keshavarz H, Clark EG, Rochwerg B, Fergusson D, Arbous S, Bauer SR, China L, Fung M, Jug R, Neill M, Paine C, Pavenski K, Shah PS, Robinson S, Shan H, Szczepiorkowski ZM, Thevenot T, Wu B, Stanworth S, Shehata N | 2024 | Chest | View Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines | Health care providers | Benchmarking and standard setting |
| Thrombotic triad in microgravity | Elahi MM, Witt AN, Pryzdial ELG, McBeth PB | 2024 | Thromb Res | View Thrombotic triad in microgravity | Researchers | Basic research |
| Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020 | Drews SJ, Charlton C, O'Brien SF, Burugu S, Denomme GA | 2024 | Vox Sang | View Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020 | Researchers | Epidemiology research |
| Mythbusters: Use of Intravenous Albumin: A Guideline from the International Collaboration for Transfusion Medicine Guidelines (ICTMG) | Callum J, Clark E, Rochwerg B, Daly J, Raza S, Vlaar A, Wolfe A | 2024 | Professionaleducation.blood.ca | View Mythbusters: Use of Intravenous Albumin: A Guideline from the International Collaboration for Transfusion Medicine Guidelines (ICTMG) | Health care providers | Benchmarking and standard setting |
| Réserves en produits plaquettaires, indications et commande | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Professionaleducation.blood.ca | View Réserves en produits plaquettaires, indications et commande | Health care providers | Benchmarking and standard setting |
| Viral coagulation: pushing the envelope | Pryzdial ELG, Perrier JR, Rashid MU, West HE, Sutherland MR | 2024 | J Thromb Haemost | View Viral coagulation: pushing the envelope | Researchers | Basic research |
| A perspective on exogenous redox regulation mediated by transfused RBCs subject to the storage lesion | William N, Acker JP | 2024 | Transfus Apher Sci | View A perspective on exogenous redox regulation mediated by transfused RBCs subject to the storage lesion | Researchers | Basic research |
| Sebum Components Dampen the Efficacy of Skin Disinfectants against Cutibacterium acnes Biofilms | Kumaran D, Ramirez-Arcos S | 2024 | Microorganisms | View Sebum Components Dampen the Efficacy of Skin Disinfectants against Cutibacterium acnes Biofilms | Researchers | Basic research |
| The selection and preparation of red cell components for intrauterine transfusion: A national survey | Bodnar M, Lieberman L, Arsenault V, Berardi P, Duncan J, Lane D, Lavoie M, McCarthy J, Morrison D, Robitaille N, Shehata N, Wilson A, Clarke G, Obstetrical tC, Pediatric Transfusion Network | 2024 | Vox Sang | View The selection and preparation of red cell components for intrauterine transfusion: A national survey | Researchers | Benchmarking and standard setting |
| Alberta’s research priorities to advance organ donation and transplantation: an ecosystem-based and consensus-driven approach to strategic research planning | Davoodi S, Gongal P, Delaney S, Acker J, Boulet D, Boulet T, Dijke E, Elliot J, Halloran K, Halpin A, Hartell D, Kemp L, Kramer A, Lam N, Mager D, Mokoena T, Pepper A, Powell L, Tandon P, Wilson M, Wilkins R, Woolfsmith J, West L | 2024 | Can Heal Pol | View Alberta’s research priorities to advance organ donation and transplantation: an ecosystem-based and consensus-driven approach to strategic research planning | Researchers | Benchmarking and standard setting |
| Safety, Acceptance, Fairness & Equality (SAFE project): Acceptable risk and donor selection | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Safety, Acceptance, Fairness & Equality (SAFE project): Acceptable risk and donor selection | General public | MSM research |
| Remembering Dr. Dana Devine | Centre for Blood Research | 2024 | Centre for Blood Research Blog | View Remembering Dr. Dana Devine | General public | Other |
| Comparative genome analyses of Staphylococcus aureus from platelet concentrates reveal rearrangements involving loss of type VII secretion genes | Ighem Chi S, Flint A, Weedmark K, Pagotto F, Ramirez-Arcos S | 2024 | Access Microbiol | View Comparative genome analyses of Staphylococcus aureus from platelet concentrates reveal rearrangements involving loss of type VII secretion genes | Researchers | Basic research |
| You’re invited to take our new Virtual Tour! | Wolfe A | 2024 | Research.Education.Discovery (R.E.D.) Blog | View You’re invited to take our new Virtual Tour! | General public | Other |
| Anemia in Hospitalized Patients: Vampirism and Other Tales | Siegal D | 2024 | Blood.ca website | View Anemia in Hospitalized Patients: Vampirism and Other Tales | Health care providers | Clinical research |
| Homing and Engraftment of Hematopoietic Stem Cells Following Transplantation: A Pre-Clinical Perspective | Hasan T, Pasala AR, Hassan D, Hanotaux J, Allan DS, Maganti HB | 2024 | Curr Oncol | View Homing and Engraftment of Hematopoietic Stem Cells Following Transplantation: A Pre-Clinical Perspective | Researchers | Clinical research |
| Extension of the circulatory half-life of recombinant ecallantide via albumin fusion without loss of anti-kallikrein activity | Al-Adimi G, Bhakta V, Eltringham-Smith LJ, Shirobokov V, Sheffield WP | 2024 | J Biotechnol | View Extension of the circulatory half-life of recombinant ecallantide via albumin fusion without loss of anti-kallikrein activity | Researchers | Basic research |
| Portée opérationnelle des options d’évaluation du risque | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Portée opérationnelle des options d’évaluation du risque | General public | MSM research |
| Transfusion-Transmitted Diseases | Drews SJ | 2024 | Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects | View Transfusion-Transmitted Diseases | Health care providers | Clinical research |
| External Trigger Free Charge Switchable Cationic Ligands in the Design of Safe and Effective Universal Heparin Antidote | La CC, Smith SA, Kalathottukaren MT, Haynes CA, Morrissey JH, Kizhakkedathu JN | 2024 | Adv Healthc Mater | View External Trigger Free Charge Switchable Cationic Ligands in the Design of Safe and Effective Universal Heparin Antidote | Researchers | Basic research |
| Prevalence of human T-cell lymphotropic virus-1/2 in Canada over 33 years: A unique contribution of blood donors to public health surveillance | O'Brien SF, Ehsani-Moghaddam B, Goldman M, Osmond L, Fan W, Drews SJ | 2024 | Can J Public Health | View Prevalence of human T-cell lymphotropic virus-1/2 in Canada over 33 years: A unique contribution of blood donors to public health surveillance | Researchers | Epidemiology research |
| A summary of recent discoveries advancing the understanding and treatment of hemophilia | Sztainert T | 2024 | Research.Education.Discovery (R.E.D.) Blog | View A summary of recent discoveries advancing the understanding and treatment of hemophilia | General public | Other |
| Hemoglobin-oxygen affinity changes in neonatal blood transfusions: RBC selection insights | Yazdanbakhsh M, Eid H, Acker JP, Bar Am N, Cheung PY, Dotchin SA, Rabi Y | 2024 | Pediatr Res | View Hemoglobin-oxygen affinity changes in neonatal blood transfusions: RBC selection insights | Researchers | Clinical research |
| Guideline No. 448: Prevention of Rh D Alloimmunization | Fung-Kee-Fung K, Wong K, Walsh J, Hamel C, Clarke G | 2024 | J Obstet Gynaecol Can | View Guideline No. 448: Prevention of Rh D Alloimmunization | Health care providers | Benchmarking and standard setting |
| Améliorer la sécurité des transfusions de plaquettes grâce à la réduction des agents pathogènes | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Améliorer la sécurité des transfusions de plaquettes grâce à la réduction des agents pathogènes | General public | Other |
| Determining the impact of current Canadian stem cell registry policy on donor availability via dynamic registry simulation | Blake JT, Ganz K, Seftel M, Allan D | 2024 | Vox Sang | View Determining the impact of current Canadian stem cell registry policy on donor availability via dynamic registry simulation | Blood operators | Benchmarking and standard setting |
| How I manage major hemorrhage | Callum JL, George RB, Karkouti K | 2024 | Blood | View How I manage major hemorrhage | Health care providers | Benchmarking and standard setting |
| Oncolytic Virus Senecavirus A Inhibits Hepatocellular Carcinoma Proliferation and Growth by Inducing Cell Cycle Arrest and Apoptosis | Gong T, Liu X, Li Q, Branch DR, Loriamini M, Wen W, Shi Y, Tan Q, Fan B, Zhou Z, Li Y, Yang C, Li S, Duan X, Chen L | 2024 | J Clin Transl Hepatol | View Oncolytic Virus Senecavirus A Inhibits Hepatocellular Carcinoma Proliferation and Growth by Inducing Cell Cycle Arrest and Apoptosis | Researchers | Clinical research |
| Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management | Loriamini M, Cserti-Gazdewich C, Branch DR | 2024 | Int J Mol Sci | View Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management | Researchers | Clinical research |
| Advancement of blood donor factors in RBC and blood component therapy using modern practices and methodologies: How to make multifactorial clinical decisions amid growing complexity | William N, Acker JP, Seghatchian J | 2024 | Transfus Apher Sci | View Advancement of blood donor factors in RBC and blood component therapy using modern practices and methodologies: How to make multifactorial clinical decisions amid growing complexity | Blood operators | New or improved product or process |
| Q&A: Restrictive or liberal transfusion strategy in myocardial infarction and anemia | Carson J, Callum J, Sztainert T | 2024 | Blood.ca website | View Q&A: Restrictive or liberal transfusion strategy in myocardial infarction and anemia | Health care providers | Benchmarking and standard setting |
| Transfusion Camp Rwanda 2023: A train-the-trainer workshop establishing locally driven leadership in knowledge translation and sustainability in transfusion medicine education | Nizeyimana F, Pendergrast J, Ntegerejuwampayee A, Lin Y, Kanyamuhunga A, Gashaija C, Masaisa F, Uzamukunda C, Mutuyimana G, Ndicunguye F, Gaseminari A, Mulindwa B, Muyombo T, Chargé S, Skelton T | 2024 | Vox Sang | View Transfusion Camp Rwanda 2023: A train-the-trainer workshop establishing locally driven leadership in knowledge translation and sustainability in transfusion medicine education | Health care providers | Education research |
| Meet the Researcher: Dr. Sandra Ramirez-Arcos | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Meet the Researcher: Dr. Sandra Ramirez-Arcos | General public | Other |
| Summer Fun and Science: The Exciting Return of the CBR Amazing Race | Centre for Blood Research | 2024 | Centre for Blood Research Blog | View Summer Fun and Science: The Exciting Return of the CBR Amazing Race | General public | Other |
| Extended supercooled storage of red blood cells | Isiksacan Z, William N, Senturk R, Boudreau L, Wooning C, Castellanos E, Isiksacan S, Yarmush ML, Acker JP, Usta OB | 2024 | Commun Biol | View Extended supercooled storage of red blood cells | Researchers | Basic research |
| Lay Science Writing Competition 2024: Understanding graft versus host disease (GvHD) | Rosenflanz K | 2024 | Centre for Blood Research Blog | View Lay Science Writing Competition 2024: Understanding graft versus host disease (GvHD) | General public | Other |
| Intravenous Albumin: Is it time to consider de-prescribing efforts? | Wolfe A | 2024 | The ORBCoN Report | View Intravenous Albumin: Is it time to consider de-prescribing efforts? | Health care providers | Benchmarking and standard setting |
| Comprendre l’immunité au Canada : études de séroprévalence de la COVID-19 | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Comprendre l’immunité au Canada : études de séroprévalence de la COVID-19 | General public | Other |
| Atténuer les risques de contamination bactérienne dans la transfusion | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Impact de la recherche | View Atténuer les risques de contamination bactérienne dans la transfusion | General public | Other |
| Higher rates of laboratory-confirmed cases of syphilis in Western Canadian blood donors compared with Eastern Canadian blood donors following a period of societal re-opening | Drews SJ, Charlton C, Tran V, Zhou HY, Hawes G, Resz I, O'Brien SF | 2024 | Vox Sang | View Higher rates of laboratory-confirmed cases of syphilis in Western Canadian blood donors compared with Eastern Canadian blood donors following a period of societal re-opening | Blood operators | Epidemiology research |
| Epidemiology of Hepatitis C over 28 years of monitoring Canadian blood donors: Insight into a low-risk undiagnosed population | O'Brien SF, Ehsani-Moghaddam B, Osmond L, Fan W, Goldman M, Drews SJ | 2024 | BMC Public Health | View Epidemiology of Hepatitis C over 28 years of monitoring Canadian blood donors: Insight into a low-risk undiagnosed population | Health care providers | Epidemiology research |
| Spatial and temporal analysis of West Nile virus infection in mosquito and human populations based on arboviral detection testing data | Talbot B, Ludwig A, O'Brien SF, Drews SJ, Ogden NH, Kulkarni MA | 2024 | Sci Rep | View Spatial and temporal analysis of West Nile virus infection in mosquito and human populations based on arboviral detection testing data | Researchers | Epidemiology research |
| CSTM 2024: Reflections from Canadian Blood Services trainees, part 1 | Yazdanbakhsh M, Paredes C | 2024 | Research.Education.Discovery (R.E.D.) Blog | View CSTM 2024: Reflections from Canadian Blood Services trainees, part 1 | General public | Other |
| Introducing a new blood product to better meet the transfusion needs of the Canadian Armed Forces | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Introducing a new blood product to better meet the transfusion needs of the Canadian Armed Forces | General public | Other |
| Immunoglobulin products | Harding SR, Cowan J, Jennings S | 2024 | Clinical Guide to Transfusion | View Immunoglobulin products | Health care providers | Benchmarking and standard setting |
| Management of Pregnancies Alloimmunized with Non-Rh and Non-K Alloantibodies | Jackson ME, Grabowska K, Lieberman L, Clarke G, Yan MTS, Canadian Obstetric Pediatric Transfusion N | 2024 | J Obstet Gynaecol Can | View Management of Pregnancies Alloimmunized with Non-Rh and Non-K Alloantibodies | Health care providers | Clinical research |